MICIS 2017 REPORT January 1 - December 31, 2017

Similar documents
Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers

The Opioid Crisis: Effectiveness of State Responses

Prescription Monitoring Program (PMP)

Caring for ME Lunch & Learn Webinar Opioid Prescribing Regulations Updates on Chapter 488 and Related Rules

MORPHINE MILLIGRAM EQUIVALENTS (MMEs) Elisabeth Fowlie Mock, MD, MPH, FAAFP Maine Quality Counts Caring For ME Webinar 11/8/2016

MeHAF Addiction Care Grantee Meeting #3 Building Capacity. October 3, :30 AM 3:30 PM Maple Hill Farms

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

MeHAF Addiction Care Learning Session #2. September 13, :30 AM 3:30 PM Augusta Civic Center

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Opioid Use Disorder and Medication Assisted Recovery: Caring For Our Communities

MeHAF Addiction Care Grantee Meeting #3 Building Capacity. May 23, :30 AM 3:30 PM Maple Hill Farms

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

Update on Maine Laws and Associated Rules on Prescribing Opioid Medication

OUD & MAR: Caring for Our Communities

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Caring for ME Lunch & Learn Webinar

Addressing the Opioid Crisis Policy Recommendations

US H.R.6 of the 115 th Congress of the United States Session

It Takes A Village to Curb the Prescription Opioid Epidemic: Supply healthcare providers with resources to improve patient safety

Opioid Treatment Program Reimbursement Re-bundling Proposal

Briefing on ARTS to Secretary Hazel October 2017

Opioid Prescribing Improvement Program

CDC Guideline for Prescribing Opioids for Chronic Pain

Update on Maine Laws and Associated Rules on Prescribing Opioid Medication

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

2016 Dr. Douglas H. Kay CPE Symposium

Maine Child Health Improvement Partnership (ME CHIP) Advisory Group Friday, February 9, 1-2 pm

MENTAL HEALTH PARITY, ETHICS, AND THE LAW:

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Addressing the Opioid Epidemic in Tennessee

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

The Wisconsin Prescription Drug Monitoring Program

Governor Baker Releases Opioid Working Group Recommendations Administration targets serious reforms to combat opioid epidemic

The Opioid Epidemic: HHS Response

Prescription Opioid Overdose in Oregon: A public health perspective

California. Prescribing and Dispensing Profile. Research current through November 2015.

Psychology s Response to the

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

Best Practices in Addiction Treatment Navigating the Road to Recovery: Pain Management, Drug Trends, Medication Assisted Treatment

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program

Meth and Opioid Abuse Prevention Efforts

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations

Prepublication Requirements

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Welcome - we will begin the webinar shortly Please read the participation tips below:

Caring for ME Pharmacy Lunch & Learn Webinars

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

Scott Kirby, M.D, Medical Director, North Carolina Medical Board. Chris Ringwalt, Dr.P.H., Senior Scientist, UNC Injury Prevention Research Center

Public Health Impacts of 2016 West Virginia Legislation

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

Daniel Blaney-Koen, JD July 2018

Section I. Short-acting opioid Prior Authorization Criteria

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

Rule Governing the Prescribing of Opioids for Pain

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

Understanding Maine s Medical Marijuana Law

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

Proposed Revision to Med (i)

BEFORE THE NORTH CAROLINA MEDICAL BOARD. In re: ) ) Marcono Raymond Hines, M.D. ) CONSENT ORDER ) Respondent. )

PREVENTING PRESCRIPTION DRUG ABUSE AND OVERDOSE JUNE 23, 2016 SHERRY L. GREEN

Aetna s Initiative on the Opioid Epidemic

Appendix F Federation of State Medical Boards

Opioid Overdose in Oregon Report to the Legislature

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Addressing PA s Opioid Abuse and Overdose Crisis

Integrated Dual Disorders Treatment (IDDT) Fidelity Scale Tips and Tools Treatment Characteristics and Organizational Characteristics

Medicaid and the Opioid Crisis

PROPOSED AMENDMENTS TO HOUSE BILL 3440

Confronting the Opioid Crisis at the State Level

2017 Legislative Policy Update

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Community Opioid Load: Concept to Action in Kingston-KFLA

D. Todd Bess, PharmD 1

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Illinois Heroin Crisis Act and Family Physicians. October 14, 2015 Hinsdale Family Medicine Residency Faculty Development Program

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

ACCG Mental Health Summit

TN Opioid Program. Erica Schlesinger, Pharm.D

OPIOID. Opioid Legislation FAQs NEED TO KNOW

An Introduction to the Opioid Epidemic: Working Together To End The Nation s Opioid Epidemic

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

MARYLAND BOARD OF PHARMACY

The 86 th Texas Legislature s Policy Response to Opioids Prepared by the Texas Orthopaedic Association

Impact of Opioid Prescribing Rules in Post Acute and Long Term Care

Vision, Hearing and Spinal Screening Programs. Implementing Changes in the Vision, Hearing and Spinal Screening Programs for School Year

Opioid Use Issues: All the Players

Medication Assisted Treatment Conference

BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Governor Raimondo s Task Force on Overdose Prevention and Intervention May 9, 2018

Table of Contents. Progress Report to Our Community Introduction... 3

Transcription:

MICIS 2017 REPORT January 1 - December 31, 2017 MICIS, the Maine Independent Clinical Information Service, has been providing evidence-based prescribing education in Maine since 2008. 2017 Program The Maine Department of Health and Human Services requested changes to the terms of the MMA s MICIS contract in 2017 to address the statewide need for opioid prescribing education delivered to prescribers. Among other components of Maine P.L. 2015, Chapter 488, the law calls for mandatory continuing medical education (CME) for prescribers, with completion of three hours of CME on the prescription of opioid medication before license renewals are cycled starting on January 1, 2018. In 2017, MICIS offered 1- to 3-hour presentations on opioid prescribing on both clinical and legal topics to inform prescribers of their legal obligations under Chapter 488 and to present clinical aspects of opioid prescribing, tapering, and acute and chronic opioid treatment. This was a change from the academic detailing one-to-one or one-to-few model to add a larger scale, one-tomany delivery system. Presentation Topics and Materials In 2017 there were 62 presentations scheduled for 1, 2 and 3 hours at hospitals, medical practices, meetings and conferences. MICIS also presented three 1-hour webinars, and presented at a pain conference and for UMA nursing students. The clinical modules and presentations on opioid prescribing were researched and developed by MICIS Academic Detailers Elisabeth Fowlie Mock, MD, MPH and Erica Pierce, MMSc., PA-C, and the presentation on Chapter 488 was created by the attorneys at the Maine Medical Association. Presentations on Opioid Prescribing: Six 30-minute presentations and related program materials on opioid prescribing were developed as part of the 2017 MICIS contract, instead of purchasing materials from ALOSA Health or another provider. 1. The genesis of the opioid crisis: How We Got Here 2. Opioid Basics: MMEs & Tapering 3. Practice Transformation & QI for Opioids/Chronic Pain 4. Harm reduction: Naloxone & MAT 5. Communication skills & difficult conversations/behavioral Health Integration 6. Non-opioid/Non-pharm treatments for acute & chronic pain The framework for these programs is Educational Outreach, formatted after Academic Detailing where evidence-based prescribing information is delivered to prescribers at or near their practice sites by specially-trained, trusted colleagues with the goals of improving best practices, clinical service delivery, and quality of care.

MICIS 2017 Report 2 Presentation on Chapter 488: The presentation on Chapter 488 was created and updated regularly by the attorneys at the Maine Medical Association. An MMA attorney presented all 1- hour presentations on Chapter 488 and legal/regulatory topics as well as the 1-hour Chapter 488 presentation at all 3-hour programs that included both clinical and legal topics. Most presentations were requested by a hospital, medical practice, specialty society, or other health care group. These presentations at medical practices, hospitals, meetings and conferences featured one hour on the Chapter 488 law or one hour with two of the clinical modules. Four of the clinical topics and the Chapter 488 presentation were combined for a 3-hour program, and all six 30-minute clinical modules were also presented for a 3-hour program. There was one 2-hour presentation. Type of Presentation Number of Presentations One hour presentation clinical topics 14 One hour presentation legal & regulatory 19 Three hour presentation clinical topics 8 Three hour presentation clinical & legal topics 20 Two hour presentation - clinical topics 1 One hour webinar clinical topics 3 webinars Regional Presentations: MICIS presented six 3-hour regional programs for large groups in: Brewer: June 14 with 141 people attending Auburn: July 19 with 131 people attending Augusta: September 19 with 105 people attending Caribou on September 27 with 50 people attending Wells on November 1 with 87 people attending Portland on December 6 with 64 people attending MICIS and AdCare Educational Institute of Maine partnered on 5 of the MICIS regional presentations, with AdCare responsible for the meeting venue logistics and online registration and MICIS responsible for the presentation, presenters and program materials. AdCare also provided online registration for the December 6 MICIS program. Webinars: MICIS presented three 1-hour webinars for Quality Counts on October 31 with 91 attending, December 5 with 101 attending, and December 13 with 75 attending. 2017 Attendance: In 2017 2204 people attended MICIS presentations and 267 people attended webinars presented by MICIS. Some individuals attended more than one of the in-person programs or webinars. Continuing Medical Education Credit The Maine Medical Education Trust approved the 2017 MICIS presentations for 1 to 3 hours of continuing medical education, depending on the length of each program. MICIS webinar attendees could also receive education credits for attending the webinars.

MICIS 2017 Report 3 Module Title How did we get here? the genesis of overprescribing of opioids & subsequent CDC Guidelines Opioid Basics: MMEs & Dose reductions Practice Transformation & QI for Opioids/Chronic Pain Harm reduction: diagnosis & treatment of opioid use disorder including MAT, naloxone prescribing, risks of co-prescribing benzodiazepines Enhancing provider communication skills, building patient/family centered care models & incorporating patient education into practice Nonopioid & nonpharm treatment of chronic pain Evidence-based recommendations Legal and Regulatory Requirements for Opioid Prescribers - Chapter 488 Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Prescribers Learning Objectives Trace the origin of the opioid crisis in America Review CDC opioid prescribing guidelines Calculate morphine milligram equivalents & evidence behind limits Discuss reduction strategies Review best practices in practice transformation for opioid prescribing Focus on team-based care including developing CSI (controlled substance initiative) teams Appropriately diagnose opioid use disorder Understand requirements and benefits of buprenorphine and naltrexone prescribing Anticipate prescribing naloxone for all patients and families at risk Review Trauma-Informed care; discuss integration strategies for behavioral health and chronic pain management Demonstrate responses to Choosing Wisely s 5 Questions Evidence-based review of alternative treatments for acute & chronic pain Discuss comprehensive acute pain management plans & reduce surgical overprescribing To alert health care practitioners to the level of concern among Maine health care policymakers about the opioid abuse and addiction crisis To provide an overview of the half dozen relevant bills considered by the 127 th Maine Legislature during its Second Regular Session in 2016 To provide a comprehensive review and analysis of P.L. 2015, Chapter 488, An Act To Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program, the legislation imposing limits on prescription opioid medication; mandating use of the Prescription Monitoring Program (PMP); and requiring specific continuing medical education (CME) for practitioners who prescribe opioid medications.

MICIS 2017 Report 4 Presenters on Clinical Topics MICIS Academic Detailers Erika Pierce, MMSc., PA-C and Elisabeth Fowlie Mock, MD, MPH, FAAFP were the primary faculty for 2017 presentations. Erika Pierce, MMSc., PA-C is a native of Maine and a 2005 graduate of the Physician Assistant Program at Nova Southeastern University in Ft. Lauderdale. Erika is a member and past president of the Maine Association of Physician Assistants. She has a diverse clinical background that includes Family Practice, Emergency Medicine, Occupational Medicine, Hospitalist and Psychiatry. She currently works for Inland Family Care in Unity. Elisabeth Fowlie Mock, MD, MPH, FAAFP received her doctorate from Vanderbilt Medical School and a Master of Public Health in Health Policy and Administration from UNC-Chapel Hill. She attended Colby College and Emory University. She is Board Certified in Family Medicine and works part-time as a Hospitalist at EMMC. She is active in leadership of the Maine Academy of Family Physicians. Erika or Elisabeth presented all 1-hour presentations on clinical topics, and one or both presented at the 3-hour programs. Other presenters included Eva Quirion, FNP, PhD; Noah Nesin, MD; Stephen Hull, MD and Peter Leighton, MD. Presentations sometimes also included short videos with information presented by Eva Quirion, FNP, PhD; Noah Nesin, MD; Peter Leighton, MD and Eric Haram, LADC. Presenters on Chapter 488 Gordon H. Smith, Esq. is Executive Vice President of the Maine Medical Association. He graduated from the University of Maine with highest distinction and from the Boston College Law School, magna cum laude. He currently serves on the Executive Committee of the AMA Advocacy Resource Center, and is a member of the Board of Directors of the Daniel Hanley Center for Health Leadership. A frequent lecturer to medical groups on various medical legal subjects, Mr. Smith has served as EVP of the MMA since September 1993. Andrew MacLean, JD is Deputy Executive Vice President & General Counsel at the Maine Medical Association. He is a graduate of Duke University, received his law degree from the University of Maine School of Law, and has represented various health care entities or interests in legislative and regulatory matters since 1992. Mr. MacLean writes and speaks frequently about issues of health law and policy. Peter Michaud, JD, RN is a nurse and attorney who serves as Associate General Counsel of the Maine Medical Association. His work involves government relations, public health policy and legal analysis. A native of Madawaska, Mr. Michaud graduated from Harvard College in 1972, the University of Maine School of Law in 1977, and the Central Maine Medical Center College of Nursing and Health Professions (now the Maine College of Health Professions) in 2011. Upon retiring from the practice of law in 2009 Mr. Michaud attended nursing school and worked as a nurse in New Hampshire at Dartmouth-Hitchcock Medical Center and Memorial Hospital. He began his work for the MMA in 2015.

MICIS 2017 Report 5 MICIS Evaluations The following charts reflect responses from MICIS evaluations in 2017. Note: the charts below are based on evaluations completed at programs when clinical topics or both clinical and legal topics were presented. 2017 MICIS Totals - Influence Will this activity impact your patient outcomes? 142 253 917 Will this activity influence your practice? Will this activity enhance your competence? 88 180 41 105 1070 1215 0 200 400 600 800 1000 1200 1400 N/A N Y

MICIS 2017 Report 6 MICIS Website The MICIS website www.micismaine.org provides information about the Maine Independent Clinical Information Service, academic detailing, the 2017 and 2018 presentations on opioid education, and related resources for health care providers. The website will be updated regularly in 2018 with the addition of new information and resources to the Opioid Education section. This section will feature a chronic pain toolkit with resources for prescribers on evidence-based alternative treatment modalities as well as resources for patients. MICIS in 2018 In 2018 MICIS will continue to focus on providing opioid education and will schedule presentations throughout the state to present an updated presentation on opioid law and regulations and two new presentations on opioid topics for health care providers. We look forward to continuing our relationship with the Maine DHHS to assist with providing education on this important topic.